DepoMed Inc. (DEPO) Tops Q1 Views
Tweet
Share
E-mailGet Alerts DEPO Hot Sheet
Join SI Premium – FREE
After the close, DepoMed Inc. (NASDAQ: DEPO) reported Q1 EPS of $1.77, $0.72 better than the analyst estimate of $1.05. Revenue for the quarter came in at $83.1 million versus the consensus estimate of $81.42 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Inhibrx, Inc. (INBX) Misses Q2 EPS by 54c
- Gemini Space Station, Inc. (GEMI) Misses Q2 EPS by 32c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
